SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
CAPPS VICKIE L

(Last) (First) (Middle)
1430 DECISION STREET

(Street)
VISTA CA 92081

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DJO INC [ DJO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Executive VP, CFO
3. Date of Earliest Transaction (Month/Day/Year)
11/20/2007
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
DJO Common Stock 11/20/2007 11/20/2007 D 33,189 D $50.25 ( 1 ) 0 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
DJO Omnibus Plan $4.05 11/20/2007 11/20/2007 D 10,000 12/19/2003 ( 2 ) 12/19/2012 DJO Common Stock 10,000 ( 3 ) 0 D
DJO Omnibus Plan $7.24 11/20/2007 11/20/2007 D 3,375 05/29/2004 05/29/2013 DJO Common Stock 3,375 ( 3 ) 0 D
DJO Omnibus Plan $25.3 11/20/2007 11/20/2007 D 30,000 12/09/2004 12/09/2013 DJO Common Stock 30,000 ( 4 ) 0 D
DJO Omnibus Plan $21.91 11/20/2007 11/20/2007 D 28,250 02/26/2005 02/26/2014 DJO Common Stock 28,250 ( 3 ) 0 D
DJO Omnibus Plan $21.91 11/20/2007 11/20/2007 D 1,750 02/26/2005 02/26/2014 DJO Common Stock 1,750 ( 4 ) 0 D
DJO Omnibus Plan $21.38 11/20/2007 11/20/2007 D 25,000 12/08/2005 12/08/2014 DJO Common Stock 25,000 ( 4 ) 0 D
DJO Omnibus Plan $39.4 11/20/2007 11/20/2007 D 16,000 04/03/2007 04/03/2016 DJO Common Stock 16,000 ( 4 ) 0 D
DJO Omnibus Plan $39.99 11/20/2007 11/20/2007 D 30,000 05/11/2008 05/11/2017 DJO Common Stock 30,000 ( 4 ) 0 D
Explanation of Responses:
1. Pursuant to the Agreement and Plan of Merger dated as of July 15, 2007, by and among ReAble Therapeutics Finance LLC, Reaction Acquisition Merger Sub, Inc. and DJO Incorporated (the "Merger Agreement"), immediately upon the effectiveness of the merger of Reaction Acquisition Merger Sub, Inc. with and into DJO Incorporated (the "Merger"), these shares of common stock were cancelled and converted into the right to receive $50.25 in cash.
2. Pursuant to the Merger Agreement, all unvested options included in Table II became fully vested and immediately exercisable on the effective date of the Merger
3. Pursuant to the Merger Agreement, these options were canceled on the effective date of the Merger and converted into the right to receive a cash payment equal to the number of shares of DJO Incorporated common stock underlying the option multiplied by the amount by which $50.25 exceeds the applicable exercise price of the option, less applicable withholding taxes.
4. Pursuant to the Merger Agreement, on the effective date of the Merger these options were exchanged for options in ReAble Therapeutics, Inc.
Remarks:
Donald M. Roberts Attorney-at-Fact 11/21/2007
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.